Licensing & Royalties >> Licensing Opportunities >> Technology Abstracts   Cancer - Research Materials: Date Ref. No. Patent No. Title 10/12/2009 E-345-2008/0 CXCR4 and CCR10 Expressing Cells: Useful for the Study of Cancer Cell Survival and Metastasis 9/17/2009 E-005-2007/0 Establishment of Two Cell Lines that Stably Express Luciferase for In Vivo Tracking 9/17/2009 E-261-2007/0 Mouse Embryonic Stem Cell-based Functional Assay to Evaluate Mutations in BRCA2 8/11/2009 E-058-2009/0 Development of a New Carbohydrate Antibody to GalNac1-3Gal 7/29/2009 E-229-2009/0 A Tumorigenic MEF/3T3 Tet-Off Mouse Fibroblast Cell Line Stably Transfected with a T7-Tagged Srp20 Expression Construct (pJR17) 7/17/2009 E-216-2009/0 High Diversity/High Affinity Domain Antibody Library 6/11/2009 E-164-2007/0 Compounds Binding to the N-Terminal Domains of STAT Proteins as Therapeutic Agents 6/8/2009 E-171-2009/0 Improved Antibodies Against ErbB4/Her4 5/28/2009 E-101-2006/0 Tools to Identify Candidates for Effective Cancer Therapy: Antibodies to Human Asparagine Synthetase 5/28/2009 E-162-2004/0 Mouse Model with Targeted Disruption of the Neurofibromatosis Type-1 (Nf1) Gene 5/15/2009 E-129-2009/0 A549 Cells: A Well-Characterized Lung Carcinoma Cell Line Utilized for a Variety of Scientific Studies, including Adenovirus Production and Testing 5/4/2009 E-154-2004/0 Creation and Characterization of Carcinogen-Altered Mouse Epidermal Cell Lines 5/4/2009 E-159-2005/0 DU145 Camptothecin (CPT)-Resistant Cell Line 5/4/2009 E-241-2005/0 Transgenic Mice in which the Gene for MCP-1 is Deleted 5/4/2009 E-053-2006/0 Polyclonal Antibody Against Bloom's Syndrome Protein (BLM) for Research and Diagnostic Use 5/4/2009 E-193-1997/0 6,555,367 Targeted Recombinant Adenoviral Vectors 2/25/2009 E-245-2003/0 Glutathione S-transferase Clones for Members of the Ubiquitin-Dependent Protein Degradation Pathway 1/1/2009 E-274-2008/0 Monoclonal Antibodies to the Tumor-Specific Antigen, Human ROR1 12/1/2008 E-003-2008/0 A Novel, Non-Invasive and Therapeutically Useful High Throughput Technique to Isolate Highly Enriched Tumor Reactive Lymphocytes from Peripheral Blood - Potential Use in Adoptive Immunotherapy 11/1/2008 E-174-2008/0 Therapeutic Targeting of CSN5, a Negative Regulator of p53 and p27, in Human Hepatocellular Carcinoma 9/1/2008 E-111-1991/0 E-111-1991/1 5,585,462 6,074,842 Human Perilipin Proteins 9/1/2008 E-163-2007/0 Bifunctional Compounds that Bind to Hormone Receptors 7/1/2008 E-091-2008/0 Method for Detection and Quantification of PLK1 Expression and Activity 5/1/2008 E-080-2008/0 Human and Improved Murine Monoclonal Antibodies Against CD22 5/1/2008 E-079-2008/0 Human Monoclonal Antibody Against Mesothelin 5/1/2008 E-281-2007/0 Multicolored Fluorescent Cell Lines for High-Throughput Angiogenesis and Cytotoxicity Screening 5/1/2008 E-316-2007/0 Method of Inhibiting ABCG2 and Related Treatments 9/1/2007 E-272-1998/0 6,790,948 7,431,926 Tumor Suppressor Genes 9/1/2007 E-153-1998/0 7,256,256 Peptide Inhibitor of Cyclin Dependent Kinase 4 (CDK4) Derived from MyoD 8/1/2007 E-068-1998/0 6,685,933 7,235,232 Interferon Alpha Hybrids 5/1/2007 E-281-2002/0 7,193,053 Leu574 of HIF-1alpha as a Molecular Basis for Therapeutic Application 5/1/2007 E-307-2004/1 Aminoalkyl Substituted O6-Benzylguanine Derivatives as Inactivators of O6-Alkylguanine-DNA Alkyltransferase and Adjuvants for Chemotherapy 1/1/2007 E-293-2006/0 Megakaryocyte Potentiation Factor as a New Serum Tumor Marker for Mesothelioma 12/1/2006 E-330-2003/0 Antisera to Detect Phosphorylated Phosphoinositide-Dependent Kinase 1 (PDK-1) 12/1/2006 E-014-2007/0 Peptide and Peptidomimetic Inhibitors of Smoothened Protein as Anti-neoplastic Agents 6/1/2006 E-336-2005/0 Novel Human IGF-1 Specific IGF-I and IGF-II Cross-Reactive Human Monoclonal Antibodies as Potential Anti-tumor Agents 3/1/2006 E-262-1999/1 7,459,536 Monoclonal Antibodies Which Specifically Bind to the Ligand Hepatocyte Growth Factor (HGF) and are Useful in the Treatment of Cancer 12/1/2005 E-323-2003/0 7,589,181 Minimally Immunogenic Variants of SDR-Grafted Humanized Antibody CC49 and Their Use 12/1/2005 E-264-2005/0 Mouse Polyclonal Antibodies to KAI1 10/1/2005 E-327-2005/0 NIH3T3 Cell Lines Carrying c-Met Mutations Including G3906A, G3522A, G3810T, T3936C, T3936G, T3997C, C3528T, C3564G, C3831G, A3529T, and T3640C 10/1/2005 E-274-2005/0 Murine Mast Cell Line Useful for Toxicity and Immunopotency Screens 10/1/2005 E-167-1997/0 7,153,866 The Use of Nitroxides in the Prophylactic and Therapeutic Treatment of Cancer Due to Genetic Defects 9/1/2005 E-327-2004/0 A New Approach Toward Macrocyclization of Peptides 9/1/2005 E-144-2005/0 Soluble Fragments of the IGF1R Ectodomain 9/1/2005 E-095-2000/2 Amelioration of Inflammatory Arthritis Targeting the Pre-ligand Assembly Domain (PLAD) of Tumor Necrosis Factor Receptors 9/1/2005 E-087-1996/0 Heterologous Boosting Immunizations 8/1/2005 E-168-2005/0 Monoclonal Antibody to the Protein NCOA6 (also called ASC-2, AIB-3) 7/1/2005 E-075-2004/2 Methods for the Identification and Use of Compounds Suitable for the Treatment of Drug Resistant Cells 6/1/2005 E-339-2004/0 Framework Residue Substituted Humanized COL-1 Antibodies and Their Use 5/1/2005 E-351-2004/0 Antibodies to Rheb, a Ras-Related Protein 5/1/2005 E-245-2004/0 Methods of Reducing the Activity and Concentration of an Eph Receptor Tyrosine Kinase 5/1/2005 E-135-2004/0 Retinal Pigment Epithelial Cells Immortalized with TERT and Expressing the Adenoviral E1A Oncoprotein 4/1/2005 E-265-1994/0 E-265-1994/1 6,255,105 6,342,392 6,737,251 7,067,635 Nucleotide and Deduced Amino Acid Sequences of a New Tumor Gene, Int6 4/1/2005 E-324-2001/2 Selections of Genes and Methods of Using the Same for Diagnosis and for Targeting the Therapy of Select Cancers 4/1/2005 E-156-2004/0 Chinese Hamster Ovary Cells Resistant to Colcemid with Altered beta-Tubulin 3/1/2005 E-105-2004/0 E-105-2004/1 Minimally Immunogenic Germline Sequence Variants of COL-1 Antibody and Their Use 3/1/2005 E-166-2001/0 7,557,196 HGC-1, A Gene Encoding a Member of the Olfactomedin-Related Protein Family 3/1/2005 E-108-2004/0 E-234-2003/0 Methods for Identifying, Diagnosing, and Predicting Survival of Lymphomas 1/1/2005 E-017-2005/0 Methods and Composition for Development of Preclinical Testing of Anticancer Therapies Using Transgenic Animals 1/1/2005 E-123-2001/0 E-124-2001/1 7,247,615 Peptide Agonists of Prostate-Specific Antigen and Uses Thereof 9/1/2004 E-243-2004/0 Vectors for Wild-Type DDR1b or DDR1b Mutant, and Production of THP-1 Cell Line Expressing Two DDR1 Isoforms, DDR1a and DDR1b 8/1/2004 E-266-2004/0 Mouse Model of PRKAR1A Down-Regulation 6/1/2004 E-112-1994/0 5,652,223 5,981,712 6,790,936 DNA Encoding CAI Resistance Proteins and Uses Thereof 5/1/2004 E-131-2004/0 AT8, a Hybridoma Cell Line Producing a Monoclonal Antibody (MAb) Specific for Ly49G, a Mouse Natural Killer (NK) Cell Receptor 3/1/2004 E-107-2004/0 Specific Antibodies to the Lymphatic Endothelial Cell Specific Hyaluronic Acid Receptor, LYVE-1 11/1/2003 E-008-2001/0 7,598,077 Compositions and Methods for Enhancing Differential Gene Expression 6/1/2003 E-091-2002/0 7,329,502 Zap70 Protein Expression as a Marker for Chronic Lymphocytic Leukemia (CLL) 5/1/2003 E-161-2003/0 Flp-in T-Rex Jurkat Cell Line 4/1/2003 E-191-2002/0 7,521,475 Chondropsin-Class Antitumor V-ATPase Inhibitor Compounds, Compositions and Methods of Use Thereof 2/1/2003 E-251-2000/0 Telomerase Immortalized Hepatocyte Cell Lines 2/1/2003 E-340-2002/0 4G10, a Monoclonal Antibody Against the Chemokine Receptor CXCR4, Raised Against a Synthetic Peptide of 38 Residues in Length Derived from the N-terminal Sequence of CXCR4 4/1/2002 E-099-2001/0 Mitochondrial Topoisomerase I 12/1/2001 E-295-2001/0 Imaging of Extracellular Proteases in Cells Using Mutant Anthrax Toxin Protective Antigens 11/1/2001 E-261-1998/0 6,969,614 Methods and Devices for Isolation and Analysis of Cellular Protein Content 8/1/2001 E-264-2001/0 H2,056 A Mouse Model of von Hippel-Lindau Disease 5/1/2001 E-203-1994/0 5,693,779 Production and Use of Anti-Dorsalizing Morphogenetic Protein 4/1/2001 E-149-2000/0 6,756,215 Biologically Active FLAG-Epitope-Tagged Transforming Growth Factor Beta (TGF-beta) Protein 3/1/2001 E-336-1987/1 5,693,778 ARG, A Human Gene Related to but Distinct from ABL Proto-Oncogene 12/1/2000 E-014-2000/0 6,600,018 7,223,853 Secreted Frizzled Related Protein, sFRP, Fragments and Methods of Use Thereof 9/1/2000 E-142-1999/0 6,362,317 6,884,873 Anti-H2A Antibody and Method for Detecting DNA Double-Stranded Breaks 9/1/1999 E-216-1994/0 6,057,346 Inhibition of Retroviral LTR Promoters by Calcium Response Modifiers 8/1/1999 E-011-1998/0 6,849,417 7,442,543 Mammalian Selenoprotein Differentially Expressed in Tumor Cells 7/1/1999 E-077-1999/0 6,623,960 7,524,939 Monoclonal Antibodies Specific And Inhibitory To Human Cytochrome P450 2C8, 2C9, 2C18 And 2C19 - New Avenues For Drug Discovery 6/1/1999 E-032-1995/0 5,650,627 Sensitive Assay for Measuring Gallium Levels in Body Tissues and Fluids 4/1/1999 E-157-1994/1 6,787,306 7,402,387 Method and Composition for Detecting Dihydropyrimidine Dehydrogenase Splicing Mutations 3/1/1999 E-071-1991/2 5,645,988 Method of Identifying and Using Drugs with Selective Effect Against Cancer Cells 10/1/1998 E-150-1998/0 6,323,325 Agents That Bind To And Inhibit Cytochrome P450 2A6 10/1/1998 E-122-1998/0 6,335,428 Agents That Bind To And Inhibit Human Cytochrome P450 1A2 10/1/1997 E-246-1988/0 5,211,657 Laminin A Peptides 5/1/1997 E-046-1997/0 6,060,253 Agents That Bind To And Inhibit Human Cytochrome P450 2D6 1/1/1997 E-160-1992/1 5,487,979 5,717,067 5,872,219 eps15, Substrate For The Epidermal Growth Factor Receptor Kinase 11/1/1996 E-185-1995/0 5,939,530 Inhibitory And Non-Inhibitory Antigen Binding Polypeptides Against Human P450 Enzymes 7/1/1996 E-094-1994/0 7,070,972 7,488,808 Janus Family Kinases (JAK) And Identification Of Immune Modulators 7/1/1996 E-221-1989/0 E-221-1989/1 5,183,884 5,480,968 5,820,859 5,916,755 6,639,060 Novel Epidermal Growth Factor Receptor (ErbB-3) And Antibodies 4/1/1996 E-029-1990/0 E-029-1990/1 5,403,926 5,702,907 5,811,262 Hepatocellular Carcinoma Oncogene 11/1/1994 E-005-1993/0 5,532,348 5,914,389 E6-Associated Protein And Methods Of Use 4/1/1994 E-116-1992/0 5,569,602 The First Immortalized Kaposi's Sarcoma Cell Line 1/1/1994 E-253-1993/0 5,437,951 5,709,996 5,716,620 5,744,142 5,756,284 5,871,998 5,985,610 7,220,419 7,361,356 Self-Assembling Recombinant Papillomavirus Capsid Proteins 12/1/1993 E-040-1993/0 5,833,986 5,863,739 Neutralizing Monoclonal Antibody To Human Alpha PDGF Receptors 2/1/1992 E-193-1990/0 5,321,014 Molecular Encapsulation and Delivery of Alkanes to Living Mammalian Cells for Risk Assessment and Pharmaceutical Applications Back

Note that this site uses cookies, Click here for more information.